These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 10401724)

  • 1. Role of diltiazem on tacrolimus pharmacokinetics in tacrolimus-induced nephrotoxic rats.
    Tada H; Yanagiwara S; Ito K; Suzuki T
    Pharmacol Toxicol; 1999 Jun; 84(6):241-6. PubMed ID: 10401724
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The interaction of the diltiazem with oral and intravenous cyclosporine in rats.
    Kalkan S; Gumustekin M; Aygoren O; Tuncok Y; Gelal A; Guven H
    Eur J Drug Metab Pharmacokinet; 2004; 29(2):119-23. PubMed ID: 15230340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is there a beneficial effect of the calcium channel blocker diltiazem on cyclosporine A nephrotoxicity in rats?
    Kuhn UD; Lupp A; Kostka E; Kühl A; Balogh A; Stein G; Fleck C
    Exp Toxicol Pathol; 1998 Sep; 50(4-6):484-90. PubMed ID: 9784027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prevention of diltiazem in tacrolimus-induced nephrotoxicity: experiment with rats].
    Chen YH; Liang YX; Chen LQ; Liang JJ; Zhang J; Qiu J; Li WL; Hu JB; Xie KJ; Zhong WD; Chen LZ; Zheng KL
    Zhonghua Yi Xue Za Zhi; 2007 Aug; 87(32):2235-7. PubMed ID: 18001539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetic changes of intravenous tacrolimus in rats with uranyl nitrate-induced acute renal failure.
    Son IJ; Moon YJ; Lee MG; Sohn YT
    Res Commun Mol Pathol Pharmacol; 2000; 108(5-6):359-68. PubMed ID: 11958289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative modulating effects of captopril, diltiazem, dietary calcium and pyridoxal-5'-phosphate on gentamicin-induced nephrotoxicity in the rat.
    Ali BH; Bashir AA
    Gen Pharmacol; 1993 Sep; 24(5):1279-83. PubMed ID: 8270187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction between FK 506 and diltiazem in an animal model.
    Regazzi MB; Iacona I; Alessiani M; Spada M; Vaccarisi S; Villani P; Molinaro M
    Transplant Proc; 1996 Apr; 28(2):1017-8. PubMed ID: 8623215
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of diltiazem on pharmacokinetics of tacrolimus in relation to CYP3A5 genotype status in renal recipients: from retrospective to prospective.
    Li JL; Wang XD; Chen SY; Liu LS; Fu Q; Chen X; Teng LC; Wang CX; Huang M
    Pharmacogenomics J; 2011 Aug; 11(4):300-6. PubMed ID: 20514078
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diltiazem minimizes tubular damage due to FK506-mediated nephrotoxicity following ischemia and reperfusion in rats.
    Becker G; Witzke O; Baltes A; Hamar P; Philipp T; Heemann U
    Transpl Immunol; 1996 Mar; 4(1):68-71. PubMed ID: 8762016
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanism of FK506-induced renal hypoperfusion and its reversion in rats.
    Chen JC; Ma P
    Acta Pharmacol Sin; 2001 Nov; 22(11):1034-8. PubMed ID: 11749797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Benefit of theophylline administration in tacrolimus-induced nephrotoxicity in rats.
    McLaughlin GE; Schober M; Perez M; Ruiz P; Steele BW; Abitbol C
    Pediatr Nephrol; 2003 Sep; 18(9):860-4. PubMed ID: 12836095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nephrotoxicity studies of the immunosuppressants tacrolimus (FK506) and ascomycin in rat models.
    Mollison KW; Fey TA; Krause RA; Andrews JM; Bretheim PT; Cusick PK; Hsieh GC; Luly JR
    Toxicology; 1998 Feb; 125(2-3):169-81. PubMed ID: 9570331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetic interaction between single oral doses of diltiazem and sirolimus in healthy volunteers.
    Böttiger Y; Säwe J; Brattström C; Tollemar J; Burke JT; Häss G; Zimmerman JJ
    Clin Pharmacol Ther; 2001 Jan; 69(1):32-40. PubMed ID: 11180036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Individualization of tacrolimus dosage basing on cytochrome P450 3A5 polymorphism--a prospective, randomized, controlled study.
    Chen SY; Li JL; Meng FH; Wang XD; Liu T; Li J; Liu LS; Fu Q; Huang M; Wang CX
    Clin Transplant; 2013; 27(3):E272-81. PubMed ID: 23432535
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Time-related clinical determinants of long-term tacrolimus pharmacokinetics in combination therapy with mycophenolic acid and corticosteroids: a prospective study in one hundred de novo renal transplant recipients.
    Kuypers DR; Claes K; Evenepoel P; Maes B; Coosemans W; Pirenne J; Vanrenterghem Y
    Clin Pharmacokinet; 2004; 43(11):741-62. PubMed ID: 15301578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. No effect of water deprivation for 48 hours on the pharmacokiinetics of intravenous tacrolimus in rats.
    Son IJ; Moon YJ; Lee MG; Sohn YT
    Res Commun Mol Pathol Pharmacol; 2000; 107(3-4):279-89. PubMed ID: 11484882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diltiazem increases tacrolimus concentrations.
    Hebert MF; Lam AY
    Ann Pharmacother; 1999 Jun; 33(6):680-2. PubMed ID: 10410178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amelioration of experimental cyclosporine nephrotoxicity by calcium channel inhibition.
    Petric R; Freeman D; Wallace C; McDonald J; Stiller C; Keown P
    Transplantation; 1992 Dec; 54(6):1103-6. PubMed ID: 1465778
    [No Abstract]   [Full Text] [Related]  

  • 19. Diltiazem increases blood concentrations of cyclized cyclosporine metabolites resulting in different cyclosporine metabolite patterns in stable male and female renal allograft recipients.
    Bleck JS; Thiesemann C; Kliem V; Christians U; Hecker H; Repp H; Frei U; Westhoff-Bleck M; Manns M; Sewing KF
    Br J Clin Pharmacol; 1996 Jun; 41(6):551-6. PubMed ID: 8799521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protective effect of selected calcium channel blockers and prednisolone, a phospholipase-A2 inhibitor, against gentamicin and carbon tetrachloride-induced nephrotoxicity.
    Akindele AJ; Adeneye AA; Olatoye F; Benebo AS
    Hum Exp Toxicol; 2014 Aug; 33(8):831-46. PubMed ID: 24220874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.